Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

J. Cuthbertson, Daniel; J. Irwin, Andrew; J. Gardner, Chris; Daousi, Christina; Purewal, Tej; Furlong, Niall; Goenka, Niru; Louise Thomas, E.; L. Adams, Valerie; Pushpakom, Sudeep; Pirmohamed, Munir; J. Kemp, Graham

doi:10.1371/journal.pone.0050117

Public

Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Published in PLoS ONE • Dec 6, 2012

Authors:

Daniel J. Cuthbertson

Andrew J. Irwin

Chris J. Gardner

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia. Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM, we determined the...

Subject

Liraglutide

Internal medicine

Exenatide

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!